Table of Contents Table of Contents
Previous Page  58 / 78 Next Page
Information
Show Menu
Previous Page 58 / 78 Next Page
Page Background

58

Vol. 66, No. 4 2015

Northeast Florida Medicine

DCMS online

. org

CME

with ileal disease.

19

Hence, patients with Crohn’s disease

should be strongly encouraged to stop smoking.

20,21

On the other hand, smoking cessation appears to be

detrimental in ulcerative colitis. The increased risk of

UC can start two years after quitting and last up to 20

years.

20

Nicotine patches may help symptoms of UC,

but a recent study failed to show significant benefit to

smoking in UC.

21

Given the adverse cardio pulmonary

effects of smoking, patients with UC should nevertheless

be encouraged to quit, and discouraged from starting.

ClostridiumDifficile Infection (CDI) and IBD

Infections with Clostridium difficile (CDI) and other

enteric pathogens, account for about 10 percent of IBD

flares and relapses.

22

Concurrent with the nationwide epi-

demic of CDI, many institutions are reporting an increase

in CDI in patients with IBD.These patients are at increased

risk for hospitalizations and complications.

23

One study

showed a colectomy rate of about 20 percent.

23

Risk factors

for CDI include antibiotic use and recent hospitalization.

CDI cannot be distinguished from IBD endoscopically;

diagnosis is based on stool testing. Immunosuppressive

drugs should be withheld until stool studies are negative

for pathogens. When diagnosed, CDI should be treated

with metronidazole or vancomycin, according to current

recommendations.

24

Some patients will develop recurrent

CDI, which can be difficult to eradicate. Reports about the

safety and efficacy of a novel treatment, Fecal Microbiota

Transplantation (FMT) in immunocompromised patients

are encouraging.

25

The study included patients with IBD

on immunosuppressive therapy.

Conclusion

In conclusion, the diagnosis and treatment of IBD re-

mains complex and multifaceted. PCPs play an important

role in the management of these patients to enable the best

outcomes. Patients with symptoms and signs suggestive

of IBD should be referred to a gastroenterologist. Those

patients should be screened for bone loss, depression,

anxiety, abnormal body image and nutritional deficiencies.

Smoking should be discouraged and the use of NSAIDs

and antibiotics should be minimized.

v